Lysophosphatidylserine Stimulates Chemotactic Migration of Colorectal Cancer Cells Through GPR34 and PI3K/Akt Pathway

被引:1
|
作者
Iida, Yuuki [1 ]
Tsuno, Nelson H. [2 ]
Kishikawa, Junko [1 ]
Kaneko, Kensuke [1 ]
Murono, Koji [1 ]
Kawai, Kazushige [1 ]
Ikeda, Toshiyuki [2 ]
Ishihara, Soichiro [1 ]
Yamaguchi, Hironori [1 ]
Sunami, Eiji [1 ]
Kitayama, Joji [1 ]
Yatomi, Yutaka [3 ]
Watanabe, Toshiaki [1 ]
机构
[1] Univ Tokyo, Fac Med Sci, Dept Surg Oncol, Tokyo 1138655, Japan
[2] Univ Tokyo, Fac Med Sci, Dept Transfus Med, Tokyo 1138655, Japan
[3] Univ Tokyo, Fac Med Sci, Dept Clin Lab Med, Tokyo 1138655, Japan
关键词
Lysophosphatidylserine; GPR34; colorectal cancer; chemotactic migration; BINDS ANIONIC PHOSPHOLIPIDS; TUMOR BLOOD-VESSELS; MONOCLONAL-ANTIBODY; AUTOTAXIN; ROLES; MICE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lysophosphatidylserine (lysoPS) is a type of lysophospholipid mediator, which is involved in allergic conditions and tumor progression. We investigated the physiological function of lysoPS on colorectal cancer (CRC) cell lines, as well as the involved receptor and signaling pathways. Materials and Methods: Expression of lysoPS receptors on six cell lines was examined by reverse transcription-polymerase chain reaction (RT-PCR). The physiological functions of lysoPS were investigated, and experiments using small interfering RNA (siRNA) or inhibitors of the signaling pathways were conducted. Results: Among the three lysoPS receptors, GPR34 was highly expressed on all cell lines. LysoPS stimulated the chemotactic migratory ability. Wortmannin inhibited the migratory ability, as well as the GPR34 knock-down, strongly suggestive of the involvement of this receptor in the PI3K/Akt pathway. Conclusion: The involved receptor and pathways in the migratory ability in response to lysoPS was demonstrated, which opens premises for targeting as a new strategy for prevention and treatment of colorectal cancer.
引用
收藏
页码:5465 / 5472
页数:8
相关论文
共 50 条
  • [31] In vitro and in vivo antineoplastic activities of solamargine in colorectal cancer through the suppression of PI3K/AKT pathway
    Liu, Aihua
    Liu, Chunying
    HISTOLOGY AND HISTOPATHOLOGY, 2024, 39 (10) : 1317 - 1328
  • [32] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [33] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [34] PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
    Zhewen Zheng
    Xue Zhang
    Jian Bai
    Long Long
    Di Liu
    Yunfeng Zhou
    Cancer Cell International, 22
  • [35] PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
    Zheng, Zhewen
    Zhang, Xue
    Bai, Jian
    Long, Long
    Liu, Di
    Zhou, Yunfeng
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [36] Sodium selenite inhibits the growth of cervical cancer cells through the PI3K/AKT pathway
    Wang, Yuanyuan
    Qi, Lei
    Guo, Sihong
    Jia, Yuehui
    Wang, Ruixiang
    Lv, Cunqi
    Zeng, Qingyu
    Gao, Ying
    Wang, Tong
    Li, Qi
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2025, 87
  • [37] BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway
    Gu, Yue
    Li, Aifang
    Sun, Hui
    Li, Xueru
    Zha, He
    Zhao, Jiali
    Xie, Jiaqing
    Zeng, Zongyue
    Zhou, Lan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (05) : 2660 - 2668
  • [38] The role of the PI3K pathway in colorectal cancer
    Papadatos-Pastos, Dionysios
    Rabbie, Roy
    Ross, Paul
    Sarker, Debashis
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 18 - 30
  • [39] Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway
    Don, M-J
    Liao, J-F
    Lin, L-Y
    Chiou, W-F
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) : 638 - 646
  • [40] Bergenin suppresses the growth of colorectal cancer cells by inhibiting PI3K/AKT/mTOR signaling pathway
    Gao, Xucan
    Wang, Yazhu
    Zhang, Jianzhuo
    Lin, Lifen
    Yao, Qi
    Xiang, Guoan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (10) : 2307 - 2313